Pulse Biosciences Insider Trades
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 8 · $26.79M
- Sales
- 7 · $2.93M
- Shares bought / sold
- 1.35M / 125.00K
- Net activity
- Net buying $23.9 million
Pulse Biosciences insider activity
Over the last 12 months, Pulse Biosciences insiders reported 22 transactions on SEC Form 4: 8 open-market purchases and 7 sales. Insiders bought $26.8 million and sold $2.9 million worth of stock, for net insider buying of $23.9 million. The largest seller was Danahy Kevin Patrick, with $2.9 million in reported sales.
The most recent filing shows Teplitsky Liane Rae (Chief Operating Officer) buying 1,001 shares at $49.95 on Sep 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PLSE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PLSE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 1, 2026 | Teplitsky Liane RaeChief Operating Officer | Buy | 1,001 | $50.00K | Form 4 |
| Aug 31, 2026 | Teplitsky Liane RaeChief Operating Officer | Buy | 1,024 | $49.97K | Form 4 |
| Aug 28, 2026 | Teplitsky Liane RaeChief Operating Officer | Buy | 1,034 | $49.99K | Form 4 |
| Aug 26, 2026 | Teplitsky Liane RaeChief Operating Officer | Buy | 1,036 | $49.97K | Form 4 |
| May 11, 2026 | DUGGAN ROBERT WDirector | Buy | 660,233 | $13.00M | Form 4 |
| May 11, 2026 | LAVIOLETTE PAUL AChief Executive Officer | Buy | 15,000 | $295.35K | Form 4 |
| May 11, 2026 | LAVIOLETTE PAUL AChief Executive Officer | Buy | 15,000 | $295.35K | Form 4 |
| May 11, 2026 | DUGGAN ROBERT WDirector | Buy | 660,233 | $13.00M | Form 4 |
| Feb 18, 2026 | Danahy Kevin PatrickChief Commercial Officer | Sale | 5,000 | $118.20K | Form 4 |
| Feb 18, 2026 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 5,000 | $7.65K | Form 4 |
| Feb 17, 2026 | Danahy Kevin PatrickChief Commercial Officer | Sale | 20,000 | $472.60K | Form 4 |
| Feb 17, 2026 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 20,000 | $30.60K | Form 4 |
| Feb 13, 2026 | Danahy Kevin PatrickChief Commercial Officer | Sale | 20,000 | $470.60K | Form 4 |
| Feb 13, 2026 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 20,000 | $30.60K | Form 4 |
| Feb 12, 2026 | Danahy Kevin PatrickChief Commercial Officer | Sale | 20,000 | $467.40K | Form 4 |
| Feb 12, 2026 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 20,000 | $30.60K | Form 4 |
| Feb 11, 2026 | Danahy Kevin PatrickChief Commercial Officer | Sale | 20,000 | $504.00K | Form 4 |
| Feb 11, 2026 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 20,000 | $30.60K | Form 4 |
| Feb 10, 2026 | Danahy Kevin PatrickChief Commercial Officer | Sale | 20,000 | $470.40K | Form 4 |
| Feb 10, 2026 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 20,000 | $30.60K | Form 4 |
| Feb 9, 2026 | Danahy Kevin PatrickChief Commercial Officer | Sale | 20,000 | $429.00K | Form 4 |
| Feb 9, 2026 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 20,000 | $30.60K | Form 4 |
| Oct 2, 2025 | Danahy Kevin PatrickChief Commercial Officer | Sale | 4,600 | $85.24K | Form 4 |
| Oct 2, 2025 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 4,600 | $7.04K | Form 4 |
| Sep 19, 2025 | Danahy Kevin PatrickChief Commercial Officer | Sale | 400 | $7.39K | Form 4 |
| Sep 19, 2025 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 400 | $612 | Form 4 |
| Sep 18, 2025 | Danahy Kevin PatrickChief Commercial Officer | Sale | 20,000 | $369.80K | Form 4 |
| Sep 18, 2025 | Danahy Kevin PatrickChief Commercial Officer | Option exercise | 20,000 | $30.60K | Form 4 |
| Sep 17, 2025 | UECKER DARRINChief Technology Officer | Option exercise | 100,000 | $400.00K | Form 4 |
| Sep 17, 2025 | UECKER DARRINChief Technology Officer | Option exercise | 61,534 | $246.14K | Form 4 |
| Sep 17, 2025 | UECKER DARRINChief Technology Officer | Sale | 20,000 | $324.20K | Form 4 |
| Sep 17, 2025 | UECKER DARRINChief Technology Officer | Option exercise | 20,000 | $80.00K | Form 4 |
| Sep 16, 2025 | UECKER DARRINChief Technology Officer | Sale | 25,000 | $407.00K | Form 4 |
| Sep 16, 2025 | UECKER DARRINChief Technology Officer | Option exercise | 25,000 | $100.00K | Form 4 |
| Sep 15, 2025 | UECKER DARRINChief Technology Officer | Sale | 25,000 | $394.25K | Form 4 |
| Sep 15, 2025 | UECKER DARRINChief Technology Officer | Option exercise | 25,000 | $100.00K | Form 4 |
| Sep 12, 2025 | UECKER DARRINChief Technology Officer | Sale | 25,000 | $358.00K | Form 4 |
| Sep 12, 2025 | UECKER DARRINChief Technology Officer | Option exercise | 25,000 | $100.00K | Form 4 |
| Sep 11, 2025 | UECKER DARRINChief Technology Officer | Sale | 25,000 | $369.50K | Form 4 |
| Sep 11, 2025 | UECKER DARRINChief Technology Officer | Option exercise | 25,000 | $100.00K | Form 4 |
| Sep 10, 2025 | DUGGAN ROBERT WDirector | Buy | 34,659 | $508.10K | Form 4 |
| Jun 13, 2025 | UECKER DARRINChief Technology Officer | Sale | 15,000 | $239.70K | Form 4 |
| Jun 12, 2025 | UECKER DARRINChief Technology Officer | Sale | 15,000 | $246.00K | Form 4 |
| Feb 3, 2025 | Zanganeh MahkamDirector | Option exercise | 30,121 | $331.33K | Form 4 |
| Jan 24, 2025 | Zanganeh MahkamDirector | Option exercise | 30,121 | $331.33K | Form 4 |
| Dec 18, 2024 | DUGGAN ROBERT WDirector | Option exercise | 49,312 | $542.43K | Form 4 |
| Dec 18, 2024 | DUGGAN ROBERT WDirector | Option exercise | 69,020 | $759.22K | Form 4 |
| Dec 18, 2024 | DUGGAN ROBERT WDirector | Option exercise | 5,187,824 | $57.07M | Form 4 |
| Dec 13, 2024 | DUGGAN ROBERT WDirector | Buy | 55,256 | $949.30K | Form 4 |
| Dec 12, 2024 | DUGGAN ROBERT WDirector | Buy | 45,404 | $777.77K | Form 4 |
| Dec 11, 2024 | DUGGAN ROBERT WDirector | Buy | 50,000 | $871.00K | Form 4 |
| Dec 11, 2024 | DUGGAN ROBERT WDirector | Buy | 6,054 | $101.34K | Form 4 |
| Dec 11, 2024 | Barrett Burke ThomasFormer President and CEO | Sale | 50,000 | $871.00K | Form 4 |
| Sep 24, 2024 | Levinson Mitchell E.Chief Strategy Officer | Option exercise | 322 | $3.54K | Form 4 |
| Sep 24, 2024 | Levinson Mitchell E.Chief Strategy Officer | Option exercise | 322 | $3.54K | Form 4 |
| Sep 24, 2024 | Levinson Mitchell E.Chief Strategy Officer | Option exercise | 322 | $3.54K | Form 4 |
| Sep 24, 2024 | Levinson Mitchell E.Chief Strategy Officer | Option exercise | 1,240 | $13.64K | Form 4 |
| Sep 24, 2024 | Levinson Mitchell E.Chief Strategy Officer | Option exercise | 3,000 | $33.00K | Form 4 |
| Sep 12, 2024 | DUGGAN ROBERT WDirector | Buy | 145,140 | $2.09M | Form 4 |
| Sep 11, 2024 | DUGGAN ROBERT WDirector | Buy | 12,800 | $189.06K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4